Page 93 - Read Online

Financial support and sponsorship prognostic factors for long‑term outcome in patients with anti‑NMDA
Nil. receptor encephalitis: an observational cohort study. Lancet Neurol
2013;12:157‑65.
15. Titulaer MJ, Dalmau J. Seizures as first symptom of anti‑NMDA
Conflicts of interest receptor encephalitis are more common in men. Neurology
There are no conflicts of interest. 2014;82:550‑1.
16. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S,
REFERENCES Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch
DR, Rosenfeld MR, Dalmau J. Anti‑N‑methyl‑D‑aspartate receptor
(NMDAR) encephalitis in children and adolescents. Ann Neurol
1. Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: 2009;66:11‑8.
excitatory times ahead. Lancet Neurol 2008;7:742‑55. 17. Kayser MS, Titulaer MJ, Gresa‑Arribas N, Dalmau J. Frequency
2. Pruss H, Dalmau J, Harms L, Holtje M, Ahnert‑Hilger G, Borowski and characteristics of isolated psychiatric episodes in
K, Stoecker W, Wandinger KP. Retrospective analysis of NMDA anti‑N‑methyl‑d‑aspartate receptor encephalitis. JAMA Neurol
receptor antibodies in encephalitis of unknown origin. Neurology 2013;70:1133‑9.
2010;75:1735‑9. 18. Pruss H, Holtje M, Maier N, Gomez A, Buchert R, Harms L,
3. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Ahnert‑Hilger G, Schmitz D, Terborg C, Kopp U, Klingbeil C, Probst
Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, C, Kohler S, Schwab JM, Stoecker W, Dalmau J, Wandinger KP. IgA
Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS. NMDA receptor antibodies are markers of synaptic immunity in slow
Causes of encephalitis and differences in their clinical presentations cognitive impairment. Neurology 2012;78:1743‑53.
in England: a multicentre, population‑based prospective study. 19. Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S,
Lancet Infect Dis 2010;10:835‑44. Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst
4. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stocker
of autoimmune N‑methyl‑D‑aspartate receptor encephalitis surpasses W, Ehrenreich H. Seroprevalence of autoantibodies against brain
that of individual viral etiologies in young individuals enrolled in the antigens in health and disease. Ann Neurol 2014;76:82‑94.
California Encephalitis Project. Clin Infect Dis 2012;54:899‑904. 20. Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin
5. Kamei S, Kuzuhara S, Ishihara M, Morita A, Taira N, Togo M, Neurol 2011;24:146‑53.
Matsui M, Ogawa M, Hisanaga K, Mizutani T, Kuno S. Nationwide 21. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti‑NMDA receptor
survey of acute juvenile female non‑herpetic encephalitis in Japan: encephalitis causing prolonged nonconvulsive status epilepticus.
relationship to anti‑N‑methyl‑D‑aspartate receptor encephalitis. Neurology 2010;75:1480‑2.
Intern Med 2009;48:673‑9. 22. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE,
6. Saraya A, Mahavihakanont A, Shuangshoti S, Sittidetboripat Rossi JE, Bien CG. Diagnostic value of N‑methyl‑D‑aspartate
N, Deesudchit T, Callahan M, Wacharapluesadee S, Wilde H, receptor antibodies in women with new‑onset epilepsy. Arch Neurol
Hemachudha T. Autoimmune causes of encephalitis syndrome 2009;66:458‑64.
in Thailand: prospective study of 103 patients. BMC Neurol 23. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman
2013;13:150. D. Extreme delta brush: a unique EEG pattern in adults with
7. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, anti‑NMDA receptor encephalitis. Neurology 2012;79:1094‑100.
Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing 24. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese
LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A.
anti‑N‑methyl‑D‑aspartate receptor encephalitis associated with N‑methyl‑D‑aspartate antibody encephalitis: temporal progression
ovarian teratoma. Ann Neurol 2007;61:25‑36. of clinical and paraclinical observations in a predominantly
8. Tachibana N, Shirakawa T, Ishii K, Takahashi Y, Tanaka K, Arima non‑paraneoplastic disorder of both sexes. Brain 2010;133:1655‑67.
K, Yoshida T, Ikeda S. Expression of various glutamate receptors 25. Titulaer MJ, Leypoldt F, Dalmau J. Antibodies to N‑methyl‑D‑aspartate
including N‑methyl‑D‑aspartate receptor (NMDAR) in an ovarian and other synaptic receptors in choreoathetosis and relapsing
teratoma removed from a young woman with anti‑NMDAR symptoms post‑herpes virus encephalitis. Mov Disord 2014;29:3‑6.
encephalitis. Intern Med 2010;49:2167‑73. 26. Pruss H, Finke C, Holtje M, Hofmann J, Klingbeil C, Probst C,
9. Moscato EH, Jain A, Peng X, Hughes EG, Dalmau J, Balice‑Gordon Borowski K, Ahnert‑Hilger G, Harms L, Schwab JM, Ploner
RJ. Mechanisms underlying autoimmune synaptic encephalitis CJ, Komorowski L, Stoecker W, Dalmau J, Wandinger KP.
leading to disorders of memory, behavior and cognition: insights N‑methyl‑D‑aspartate receptor antibodies in herpes simplex
from molecular, cellular and synaptic studies. Eur J Neurosci encephalitis. Ann Neurol 2012;72:902‑11.
2010;32:298‑309. 27. Baizabal‑Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum
10. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, of movement disorders in children with anti‑NMDA receptor
Balice‑Gordon RJ. Acute mechanisms underlying antibody effects encephalitis. Mov Disord 2013;28:543‑7.
in anti‑N‑methyl‑D‑aspartate receptor encephalitis. Ann Neurol 28. Stamelou M, Plazzi G, Lugaresi E, Edwards MJ, Bhatia KP. The
2014;76:108‑19. distinct movement disorder in anti‑NMDA receptor encephalitis
11. Dalmau J, Lancaster E, Martinez‑Hernandez E, Rosenfeld MR, may be related to status dissociatus: a hypothesis. Mov Disord
Balice‑Gordon R. Clinical experience and laboratory investigations 2012;27:1360‑3.
in patients with anti‑NMDAR encephalitis. Lancet Neurol 29. Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti
2011;10:63‑74. CF, Lennon VA, Kantarci OH. N‑methyl‑D‑aspartate receptor
12. Planaguma J, Leypoldt F, Mannara F, Gutierrez‑Cuesta J, autoimmune encephalitis presenting with opsoclonus‑myoclonus:
Martin‑Garcia E, Aguilar E, Titulaer MJ, Petit‑Pedrol M, Jain A, treatment response to plasmapheresis. Arch Neurol 2011;68:1069‑72.
Balice‑Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau 30. Kataoka H, Dalmau J, Taoka T, Ueno S. Reduced N‑acetylaspartate
J. Human N‑methyl D‑aspartate receptor antibodies alter memory in the basal ganglia of a patient with anti‑NMDA receptor encephalitis.
and behaviour in mice. Brain 2015;138:94‑109. Mov Disord 2009;24:784‑6.
13. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai 31. McKeon A, Lennon VA. NMDAR encephalitis: which specimens, and
M, Dessain SK, Rosenfeld MR, Balice‑Gordon R, Lynch DR. the value of values. Lancet Neurol 2014;13:133‑5.
Anti‑NMDA‑receptor encephalitis: case series and analysis of the 32. Gresa‑Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken
effects of antibodies. Lancet Neurol 2008;7:1091‑8. L, Leypoldt F, Gleichman AJ, Balice‑Gordon R, Rosenfeld MR,
14. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Lynch D, Graus F, Dalmau J. Antibody titres at diagnosis and during
Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez‑Hernandez follow‑up of anti‑NMDA receptor encephalitis: a retrospective study.
E, Aguilar E, Gresa‑Arribas N, Ryan‑Florance N, Torrents A, Saiz A, Lancet Neurol 2014;13:167‑77.
Rosenfeld MR, Balice‑Gordon R, Graus F, Dalmau J. Treatment and 33. Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi

84 Neuroimmunol Neuroinflammation | Volume 3 | March 28, 2016